301509.SZ
金凯生科
SZSE · C 制造业 · CN
CNY 29.47
−4.38%Year over year
Reported trailing growth
- Revenue
- +11.3%
- EBITDA
- —
- EBIT
- +13.7%
- EPS
- +7.7%
- Free cash flow
- +3.8%
- Operating cash flow
- +10.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.7%
- EBITDA
- -9.5%
- EBIT
- -14.5%
- Net income
- -13.4%
- EPS
- -29.7%
- Free cash flow
- +3.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026